Effect of intravenous recombinant erythropoietin administration on plasma and erythrocyte magnesium concentrations in patients on hemodialysis

Nephron. 1996;74(2):499-500. doi: 10.1159/000189414.
No abstract available

Publication types

  • Letter

MeSH terms

  • Erythrocytes / drug effects
  • Erythrocytes / metabolism*
  • Erythropoietin / pharmacology*
  • Female
  • Humans
  • Injections, Intravenous
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy
  • Kinetics
  • Magnesium / blood*
  • Male
  • Middle Aged
  • Recombinant Proteins / pharmacology
  • Renal Dialysis*
  • Time Factors

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Magnesium